In order to determine whether an α1-adrenergic mechanism is involved in the secretion of Growth Hormone (GH) in humans, we studied the effect of the α1-adrenergic-stimulating agent methoxamine on serum GH levels in twelve normal males (age range 22-32 years). Intravenous infusion of methoxamine (dose: 6 μg/kg/min; duration: 150 min) significantly reduced serum GH levels at time 120 and 150, and on integrated concentrations. These data suggest that α1-adrenergic receptors inhibit tonic GH secretion in humans
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
Intravenous administration of methoxamine (METHOX, 5 mg, iv), a specific \u3b11-adrenergic agonist, ...
growth hormone secretion has been difficult to establish previously, possibly because of the sup-pre...
In a double-blind study in normal subjects, methoxamine, a highly selective agonist at alpha-1-adren...
GH secretagogues (GHSs) act via specific receptors in the hypothalamus and the pituitary gland to re...
Ghrelin is an endogenous ligand of the growth hormone secretagogue receptors (GHS-Rs), two subtypes ...
The effect of acute administration of human growth hormone (HGH) and of alpha-melanocyte stimulating...
The effect of acute administration of human growth hormone (HGH) and of alpha-melanocyte stimulating...
GH secretagogues (GHSs) act via specific receptors in the hypothalamus and the pituitary gland to re...
Hexarelin (Hex) is a new synthetic hexapeptide with potent GH-releasing activity in both animals and...
Hexarelin (Hex) is a new synthetic hexapeptide with potent GH-releasing activity in both animals and...
The hypothalamus-pituitary-adrenal (HPA) axis exerts a variety of effects at both the central and pe...
It is well established that compounds that modify dopaminergic and cholinergic activity in man may i...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
Intravenous administration of methoxamine (METHOX, 5 mg, iv), a specific \u3b11-adrenergic agonist, ...
growth hormone secretion has been difficult to establish previously, possibly because of the sup-pre...
In a double-blind study in normal subjects, methoxamine, a highly selective agonist at alpha-1-adren...
GH secretagogues (GHSs) act via specific receptors in the hypothalamus and the pituitary gland to re...
Ghrelin is an endogenous ligand of the growth hormone secretagogue receptors (GHS-Rs), two subtypes ...
The effect of acute administration of human growth hormone (HGH) and of alpha-melanocyte stimulating...
The effect of acute administration of human growth hormone (HGH) and of alpha-melanocyte stimulating...
GH secretagogues (GHSs) act via specific receptors in the hypothalamus and the pituitary gland to re...
Hexarelin (Hex) is a new synthetic hexapeptide with potent GH-releasing activity in both animals and...
Hexarelin (Hex) is a new synthetic hexapeptide with potent GH-releasing activity in both animals and...
The hypothalamus-pituitary-adrenal (HPA) axis exerts a variety of effects at both the central and pe...
It is well established that compounds that modify dopaminergic and cholinergic activity in man may i...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...
A specific alpha2-adrenoceptor antagonist (idazoxan) was used in man to examine the neuroregulation ...